[ad_1]
On Thursday, the World Health Organization announced its approval of the emergency use of the emerging coronavirus, which US “Pfizer” and German “Biontech” worked to develop.
With this announcement, the Pfizer vaccine will be the first to be approved for use by the organization.
The organization said, in a tweet on Twitter, that the Pfizer vaccine is “the first vaccine to gain approval from the World Health Organization for use in emergencies since the start of the outbreak.”
“Fair global access to vaccines is crucial,” he added.
The Pfizer / BioNTech # COVID-19 The vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
Equitable global access to vaccines is essential to combat the pandemic.
👉 https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
– World Health Organization (WHO) (@WHO) December 31, 2020
Britain was the first country in the world to accept an emergency use of the Pfizer vaccine, followed by Bahrain and Canada, before being licensed in the United States and several countries around the world.
According to the World Health Organization, its approval “opens the door for countries to accelerate their regulatory approval processes to import and distribute the vaccine.”
The organization said its approval of the vaccine came after experts from around the world reviewed data related to the safety, efficacy and quality of the Pfizer vaccine. Which met their criteria and requirements for the approval of various treatments and vaccines.
The organization’s deputy director general, Marie-Angela Siamao, confirmed that her cadres are working on evaluating other vaccines against the epidemic, and that the door is open for more developers to present the vaccines they were able to reach.
The Pfizer vaccine is one of the most effective vaccines, compared to the Chinese, Russian and British vaccines, with an efficacy of more than 94 percent.
The United States aims to vaccinate 100 million people before the end of the first quarter of 2021 and another 100 million before the end of the second quarter.
So far, the US health authorities have agreed to distribute two vaccines belonging to Pfizer and “Moderna.” The vaccination campaign began on December 14.
The Pfizer vaccine works by using mRNA technology, which stimulates the body to make the protein on the surface of the virus.
Once that protein is produced, the immune system will believe that the emerging corona virus is present in the body and then it will begin to produce antibodies, as if one had already contracted the disease.
[ad_2]
